Deepankar Chakroborty - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Deepankar Chakroborty

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Molecular Oncology|December 24, 2025

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapiesVeera K Ojala, Sini Ahonen, Sara Peltola, et al.

Cell Reports|February 22, 2018

Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T CellsUbaid Ullah, Syed Bilal Ahmad Andrabi, Subhash Kumar Tripathi, et al.

Nature Genetics|June 11, 2026

Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy responseAmanda R Moore, Brian Biehs, Noelyn Kljavin, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Molecular Oncology|December 24, 2025

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapiesVeera K Ojala, Sini Ahonen, Sara Peltola, et al.

Cell Reports|February 22, 2018

Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T CellsUbaid Ullah, Syed Bilal Ahmad Andrabi, Subhash Kumar Tripathi, et al.

Nature Genetics|June 11, 2026

Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy responseAmanda R Moore, Brian Biehs, Noelyn Kljavin, et al.

Pageof 2